← SynDRA
DEVAZEPIDE
SynDRA canonical compound SYN0000360 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CCKAR |
|---|
| Mechanism of action | CCK receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- CCK receptor antagonist
- CCKAR ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABCB11
- TSPO
- GLP1R
- ADRB2
- HTR2B
- FFAR4
- HTR7
- HTR1A
- HTR1B
- HTR1D
- HTR1E
- HTR2A
- HTR2C
- HTR3A
- HTR5A
- HTR6
- OGG1
- NTHL1
- HRH3
- OPRD1
- OPRK1
- OPRM1
- S1PR1
- SLC6A2
- SLC6A3
- SLC6A4
- SMUG1
- TDG
- TDP1
- TMEM97
- HRH4
- GPR65
- HRH1
- CHRM4
- ADRA1A
- ADRA1B
- ADRA1D
- ADRA2A
- ADRA2B
- ADRA2C
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- ANDR
- ATAD5
- CP19A
- CP2C9
- ESR1
- ESR2
- ESRRA
- GLI3
- KSYK
- NF2L2
- NR1H4
- PPARD
- PPARG
- SYK
Drug classes
Cross-references
Synonyms
- Devazepida
- L-364,718
- L-364718
- MK-329
- MK 329
- Devazepidum
- UNII-JE6P7QY7NH
- (S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide
- JE6P7QY7NH
- CHEMBL9506
- CHEBI:4460
- 3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one
- NCGC00159551-01
- DSSTox_RID_81331
- DSSTox_CID_26092
- DSSTox_GSID_46092
- 1H-Indole-2-carboxamide,
- L 364,718
- BRN 5156082
- DTXCID0026092
- MK329
- RefChem:388921
- L364,718
- CAS-103420-77-5
- Devazepide [USAN:INN]
- Devazepidum [INN-Latin]
- Devazepida [INN-Spanish]
- Devacade
- Devazepide (Standard)
- DEVAZEPIDE [INN]
- Devazepide (USAN/INN)
- DEVAZEPIDE [USAN]
- CCK antagonist synthetic 17
- CCK antagonist synthetic 18
- SCHEMBL148766
- orb1707386
- orb3033025
- SCHEMBL29406251
Look up DEVAZEPIDE in the interactive SynDRA portal →